Advanced search
Publication Cover
Current Eye Research Volume 14, 1995 - Issue 9
Submit an article Journal homepage
86
Views
69
CrossRef citations to date
0
Altmetric
Original Article

Biodegradation and tissue reaction to intravitreous biodegradable poly(D,L-lactic-co-glycolic)acid microspheres

Giovanni G. Giordano Department of Ophthalmology, University of Texas Health Science Center, 6411 Fannin, Houston, TX, 77027, USA; Department of Ophthalmology, University of Genoa Medical School, V.le Benedetto XV 10, Pad 9/II, Genoa, Italy, 16136
,
Patricia Chevez-Barrios Department of Ophthalmology, University of Texas Health Science Center, 6411 Fannin, Houston, TX, 77027, USA
,
Miguel F. Refojo Schepens Eye Research Institute, Department of Ophthalmology, Harvard Medical School, 20 Staniford St, Boston, MA, 02114, USA
&
Charles A. Garcia Department of Ophthalmology, University of Texas Health Science Center, 6411 Fannin, Houston, TX, 77027, USA
Pages 761-768 | Received 19 Sep 1994, Accepted 17 Feb 1995, Published online: 02 Jul 2009

Citations (69)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (5)

Whitney Shatz, Jeffrey Aaronson, Stefan Yohe, Robert F. Kelley & Yogeshvar N. Kalia. (2019) Strategies for modifying drug residence time and ocular bioavailability to decrease treatment frequency for back of the eye diseases. Expert Opinion on Drug Delivery 16:1, pages 43-57.
Read now
Qianni Wu, Dong Liu, Xulin Zhang, Dongni Wang, Meimei DongYe, Wan Chen, Duoru Lin, Fangming Zhu, Weirong Chen & Haotian Lin. (2019) Development and effects of tacrolimus-loaded nanoparticles on the inhibition of corneal allograft rejection. Drug Delivery 26:1, pages 290-299.
Read now
Miki Honda, Tomohiro Asai, Naoto Oku, Yoshihiko Araki, Minoru Tanaka & Nobuyuki Ebihara. (2013) Liposomes and nanotechnology in drug development: focus on ocular targets. International Journal of Nanomedicine 8, pages 495-504.
Read now
Kumar G Janoria, Sriram Gunda, Sai HS Boddu & Ashim K Mitra. (2007) Novel approaches to retinal drug delivery. Expert Opinion on Drug Delivery 4:4, pages 371-388.
Read now
Tony L. Whateley. (1996) Literature Alerts. Drug Delivery 3:3, pages 201-218.
Read now

Articles from other publishers (64)

Henry T. Hsueh, Renee Ti Chou, Usha Rai, Wathsala Liyanage, Yoo Chun Kim, Matthew B. Appell, Jahnavi Pejavar, Kirby T. Leo, Charlotte Davison, Patricia Kolodziejski, Ann Mozzer, HyeYoung Kwon, Maanasa Sista, Nicole M. Anders, Avelina Hemingway, Sri Vishnu Kiran Rompicharla, Malia Edwards, Ian Pitha, Justin Hanes, Michael P. Cummings & Laura M. Ensign. (2023) Machine learning-driven multifunctional peptide engineering for sustained ocular drug delivery. Nature Communications 14:1.
Crossref
Alicia Arranz-Romera, Maria Hernandez, Patricia Checa-Casalengua, Alfredo Garcia-Layana, Irene T. Molina-Martinez, Sergio Recalde, Michael J. Young, Budd A. Tucker, Rocío Herrero-Vanrell, Patricia Fernandez-Robredo & Irene Bravo-Osuna. (2021) A Safe GDNF and GDNF/BDNF Controlled Delivery System Improves Migration in Human Retinal Pigment Epithelial Cells and Survival in Retinal Ganglion Cells: Potential Usefulness in Degenerative Retinal Pathologies. Pharmaceuticals 14:1, pages 50.
Crossref
Vanessa Andrés-Guerrero, Irene T. Molina-Martínez, Irene Bravo-Osuna & Rocío Herrero-Vanrell. 2021. Ophthalmic Product Development. Ophthalmic Product Development 381 407 .
Yong Koo Kang, Han Sang Park, Dong Ho Park & Jae Pil Shin. (2020) Incidence and treatment outcomes of secondary epiretinal membrane following intravitreal injection for diabetic macular edema. Scientific Reports 10:1.
Crossref
Raquel Boia, Paulo A.N. Dias, Joana M. Martins, Caridad Galindo-Romero, Inês D. Aires, Manuel Vidal-Sanz, Marta Agudo-Barriuso, Hermínio C. de Sousa, António Francisco Ambrósio, Mara E.M. Braga & Ana Raquel Santiago. (2019) Porous poly(ε-caprolactone) implants: A novel strategy for efficient intraocular drug delivery. Journal of Controlled Release 316, pages 331-348.
Crossref
Evan A. Thackaberry, Florence Lorget, Cindy Farman & Vladimir Bantseev. (2019) The safety evaluation of long-acting ocular delivery systems. Drug Discovery Today 24:8, pages 1539-1550.
Crossref
Julieta C. Imperiale, Gabriela B. Acosta & Alejandro Sosnik. (2018) Polymer-based carriers for ophthalmic drug delivery. Journal of Controlled Release 285, pages 106-141.
Crossref
Ignacio Melgar-Asensio, Irawati Kandela, Fraser Aird, Soesiawati R. Darjatmoko, Cristobal de los Rios, Christine M. Sorenson, Daniel M. Albert, Nader Sheibani & Jack Henkin. (2018) Extended Intravitreal Rabbit Eye Residence of Nanoparticles Conjugated With Cationic Arginine Peptides for Intraocular Drug Delivery: In Vivo Imaging. Investigative Opthalmology & Visual Science 59:10, pages 4071.
Crossref
Eugene Lih, Chang Hun Kum, Wooram Park, So Young Chun, Youngjin Cho, Yoon Ki Joung, Kwang-Sook Park, Young Joon Hong, Dong June Ahn, Byung-Soo Kim, Tae Gyun Kwon, Myung Ho Jeong, Jeffrey A. Hubbell & Dong Keun Han. (2018) Modified Magnesium Hydroxide Nanoparticles Inhibit the Inflammatory Response to Biodegradable Poly(lactide- co -glycolide) Implants . ACS Nano 12:7, pages 6917-6925.
Crossref
Nasir Mat Nor, Cindy X. Guo, Ilva D. Rupenthal, Ying-Shan Chen, Colin R. Green & Monica L. Acosta. (2018) Sustained Connexin43 Mimetic Peptide Release From Loaded Nanoparticles Reduces Retinal and Choroidal Photodamage. Investigative Opthalmology & Visual Science 59:8, pages 3682.
Crossref
Fengxiang Wang, Shouzhi He & Bin Chen. (2018) Retinoic acid-loaded alginate microspheres as a slow release drug delivery carrier for intravitreal treatment. Biomedicine & Pharmacotherapy 97, pages 722-728.
Crossref
Min Zhao, Esther Rodríguez-Villagra, Laura Kowalczuk, Manon Le Normand, Marianne Berdugo, Rinath Levy-Boukris, Ikram El Zaoui, Béatrice Kaufmann, Robert Gurny, Irene Bravo-Osuna, Irene T. Molina-Martínez, Rocío Herrero-Vanrell & Francine Behar-Cohen. (2017) Tolerance of high and low amounts of PLGA microspheres loaded with mineralocorticoid receptor antagonist in retinal target site. Journal of Controlled Release 266, pages 187-197.
Crossref
Laura Fernández-Sánchez, Irene Bravo-Osuna, Pedro Lax, Alicia Arranz-Romera, Victoria Maneu, Sergio Esteban-Pérez, Isabel Pinilla, María del Mar Puebla-González, Rocío Herrero-Vanrell & Nicolás Cuenca. (2017) Controlled delivery of tauroursodeoxycholic acid from biodegradable microspheres slows retinal degeneration and vision loss in P23H rats. PLOS ONE 12:5, pages e0177998.
Crossref
Cristina García-Caballero, Esther Prieto-Calvo, Patricia Checa-Casalengua, Elena García-Martín, Vicente Polo-Llorens, Julián García-Feijoo, Irene Teresa Molina-Martínez, Irene Bravo-Osuna & Rocío Herrero-Vanrell. (2017) Six month delivery of GDNF from PLGA/vitamin E biodegradable microspheres after intravitreal injection in rabbits. European Journal of Pharmaceutical Sciences 103, pages 19-26.
Crossref
Rini Rachel Joseph & Subbu S Venkatraman. (2017) Drug delivery to the eye: what benefits do nanocarriers offer?. Nanomedicine 12:6, pages 683-702.
Crossref
Eva M. del Amo, Anna-Kaisa Rimpelä, Emma Heikkinen, Otto K. Kari, Eva Ramsay, Tatu Lajunen, Mechthild Schmitt, Laura Pelkonen, Madhushree Bhattacharya, Dominique Richardson, Astrid Subrizi, Tiina Turunen, Mika Reinisalo, Jaakko Itkonen, Elisa Toropainen, Marco Casteleijn, Heidi Kidron, Maxim Antopolsky, Kati-Sisko Vellonen, Marika Ruponen & Arto Urtti. (2017) Pharmacokinetic aspects of retinal drug delivery. Progress in Retinal and Eye Research 57, pages 134-185.
Crossref
S. Browne, K.R. Kam, F.S. Angeli, R. Gupta, Y. Yeghiazarians, K. Mehtani & K.E. Healy. 2017. Comprehensive Biomaterials II. Comprehensive Biomaterials II 273 287 .
. 2016. Biomaterials and Nanotechnology for Tissue Engineering. Biomaterials and Nanotechnology for Tissue Engineering 153 167 .
Ronakorn Panjaphongse & Jay M. Stewart. (2016) VITREOMACULAR TRACTION AFTER DEXAMETHASONE INTRAVITREAL IMPLANT (OZURDEX) INJECTION. RETINAL Cases & Brief Reports 10:1, pages 55-57.
Crossref
Nathaniel J. Kim, Alon Harris, Alhasan Elghouche, Willy Gama & Brent Siesky. 2016. Nano-Biomaterials For Ophthalmic Drug Delivery. Nano-Biomaterials For Ophthalmic Drug Delivery 177 209 .
Tai-Chi Lin, Kuo-Hsuan Hung, Chi-Hsien Peng, Jorn-Hon Liu, Lin-Chung Woung, Ching-Yao Tsai, Shih-Jen Chen, Yan-Ting Chen & Chih-Chien Hsu. (2015) Nanotechnology-based drug delivery treatments and specific targeting therapy for age-related macular degeneration. Journal of the Chinese Medical Association 78:11, pages 635-641.
Crossref
Ying-Shan Chen, Colin R. Green, Helen V. Danesh-Meyer & Ilva D. Rupenthal. (2015) Neuroprotection in the treatment of glaucoma – A focus on connexin43 gap junction channel blockers. European Journal of Pharmaceutics and Biopharmaceutics 95, pages 182-193.
Crossref
Ying-Shan Chen, Colin R. Green, Kailun Wang, Helen V. Danesh-Meyer & Ilva D. Rupenthal. (2015) Sustained intravitreal delivery of connexin43 mimetic peptide by poly(d,l-lactide-co-glycolide) acid micro- and nanoparticles – Closing the gap in retinal ischaemia. European Journal of Pharmaceutics and Biopharmaceutics 95, pages 378-386.
Crossref
Ali M. Al-Halafi. (2014) Nanocarriers of nanotechnology in retinal diseases. Saudi Journal of Ophthalmology 28:4, pages 304-309.
Crossref
Rocío Herrero-Vanrell, Irene Bravo-Osuna, Vanessa Andrés-Guerrero, Marta Vicario-de-la-Torre & Irene Teresa Molina-Martínez. (2014) The potential of using biodegradable microspheres in retinal diseases and other intraocular pathologies. Progress in Retinal and Eye Research 42, pages 27-43.
Crossref
Raghu Raj Singh Thakur, Hannah L. McMillan & David S. Jones. (2014) Solvent induced phase inversion-based in situ forming controlled release drug delivery implants. Journal of Controlled Release 176, pages 8-23.
Crossref
Roger Y Tam, Tobias Fuehrmann, Nikolaos Mitrousis & Molly S Shoichet. (2013) Regenerative Therapies for Central Nervous System Diseases: a Biomaterials Approach. Neuropsychopharmacology 39:1, pages 169-188.
Crossref
Sanja Turturro, Suhair Sunoqrot, Hongyu Ying, Seungpyo Hong & Beatrice Y. J. T. Yue. (2013) Sustained Release of Matrix Metalloproteinase-3 to Trabecular Meshwork Cells Using Biodegradable PLGA Microparticles. Molecular Pharmaceutics 10:8, pages 3023-3032.
Crossref
Kapil G. Kapoor, Ryan W. Shultz & Raymond Iezzi. (2013) Vitreous Pillow for Sustained-Release Intravitreous Drug Delivery Implants. Ophthalmic Surgery, Lasers and Imaging Retina 44:2, pages 181-182.
Crossref
Pho Nguyen, Alex Huang & Samuel C. Yiu. (2013) Nanobiotechnology in the Management of Glaucoma. Open Journal of Ophthalmology 03:04, pages 127-133.
Crossref
R. Herrero-Vanrell, M. Vicario de la Torre, V. Andrés-Guerrero, D. Barbosa-Alfaro, I.T. Molina-Martínez & I. Bravo-Osuna. (2013) Nano and microtechnologies for ophthalmic administration, an overview. Journal of Drug Delivery Science and Technology 23:2, pages 75-102.
Crossref
Xiao-feng Zhu & Hai-dong Zou. (2012) PEDF in Diabetic Retinopathy: A Protective Effect of Oxidative Stress. Journal of Biomedicine and Biotechnology 2012, pages 1-8.
Crossref
Ling Zou, Ashwin Nair, Hong Weng, Yi-Ting Tsai, Zhibing Hu & Liping Tang. (2011) Intraocular Pressure Changes: An Important Determinant of the Biocompatibility of Intravitreous Implants. PLoS ONE 6:12, pages e28720.
Crossref
Janine Jansen, Steven A. Koopmans, Leonoor I. Los, Roelofje J. van der Worp, Johanna G. Podt, Johanna M.M. Hooymans, Jan Feijen & Dirk W. Grijpma. (2011) Intraocular degradation behavior of crosslinked and linear poly(trimethylene carbonate) and poly(d,l-lactic acid). Biomaterials 32:22, pages 4994-5002.
Crossref
Kevin Letchford, Anders Södergard, David Plackett, Samuel E. Gilchrist & Helen M. Burt. 2011. Biodegradable Polymers in Clinical Use and Clinical Development. Biodegradable Polymers in Clinical Use and Clinical Development 317 365 .
K.R. Kam, F.S. Angeli, R. Gupta, Y. Yeghiazarians, K. Mehtani & K.E. Healy. 2011. Comprehensive Biomaterials. Comprehensive Biomaterials 393 404 .
Susan S. Lee, Patrick Hughes, Aron D. Ross & Michael R. Robinson. 2011. Drug Product Development for the Back of the Eye. Drug Product Development for the Back of the Eye 185 230 .
Rocío Herrero-Vanrell. 2011. Drug Product Development for the Back of the Eye. Drug Product Development for the Back of the Eye 231 259 .
Susan S. Lee, Patrick Hughes, Aron D. Ross & Michael R. Robinson. (2010) Biodegradable Implants for Sustained Drug Release in the Eye. Pharmaceutical Research 27:10, pages 2043-2053.
Crossref
Noriyuki Kuno & Shinobu Fujii. (2010) Biodegradable Intraocular Therapies for Retinal Disorders. Drugs & Aging 27:2, pages 117-134.
Crossref
Sai H.S. BodduJwala JwalaRavi VaishyaRavinder EarlaPradeep K. KarlaDhananjay PalAshim K. Mitra. (2010) Novel Nanoparticulate Gel Formulations of Steroids for the Treatment of Macular Edema. Journal of Ocular Pharmacology and Therapeutics 26:1, pages 37-48.
Crossref
Joana Araújo, Elisabet Gonzalez, Maria Antonia Egea, Marisa Luisa Garcia & Eliana B. Souto. (2009) Nanomedicines for ocular NSAIDs: safety on drug delivery. Nanomedicine: Nanotechnology, Biology and Medicine 5:4, pages 394-401.
Crossref
Emilia Barcia, Rocío Herrero-Vanrell, Ana Díez, Consuelo Alvarez-Santiago, Isabel López & Margarita Calonge. (2009) Downregulation of endotoxin-induced uveitis by intravitreal injection of polylactic-glycolic acid (PLGA) microspheres loaded with dexamethasone. Experimental Eye Research 89:2, pages 238-245.
Crossref
Gottfried Lemperle, Nelly Gauthier-Hazan, Marianne Wolters, Marita Eisemann-Klein, Ute Zimmermann & David M. Duffy. (2009) Foreign Body Granulomas after All Injectable Dermal Fillers: Part 1. Possible Causes. Plastic and Reconstructive Surgery 123:6, pages 1842-1863.
Crossref
Jing Zou, Jonna Asukas, Taija Inha, Esko Toppila, Minna Kellomäki & Ilmari Pyykkö. (2008) Biocompatibility of Different Biopolymers After Being Implanted Into the Rat Cochlea. Otology & Neurotology 29:5, pages 714-719.
Crossref
M.S. Ward, A. Khoobehi, E.B. Lavik, R. Langer & M.J. Young. (2007) Neuroprotection of Retinal Ganglion Cells in DBA/2J Mice With GDNF-Loaded Biodegradable Microspheres. Journal of Pharmaceutical Sciences 96:3, pages 558-568.
Crossref
R.R. ResendeH.A.M. TorresK.K. Yuahasi, P MajumderH Ulrich. (2017) Delivery Systems for in Vivo use of Nucleic Acid Drugs. Drug Target Insights 2, pages 117739280700200.
Crossref
R. Herrero-Vanrell & I.T. Molina-Martinez. (2007) PLA and PLGA microparticles for intravitreal drug delivery: an overview. Journal of Drug Delivery Science and Technology 17:1, pages 11-17.
Crossref
Elias Fattal & Amélie Bochot. (2006) Ocular delivery of nucleic acids: antisense oligonucleotides, aptamers and siRNA. Advanced Drug Delivery Reviews 58:11, pages 1203-1223.
Crossref
Hong Li, Veronique V. Tran, Yueyue Hu, W. Mark Saltzman, Colin J. Barnstable & Joyce Tombran-Tink. (2006) A PEDF N-terminal peptide protects the retina from ischemic injury when delivered in PLGA nanospheres. Experimental Eye Research 83:4, pages 824-833.
Crossref
A.C. Rincón, I. T. Molina-Martinez, B. de las Heras, M. Alonso, C. Baílez, J.C. Rodríguez-Cabello & R. Herrero-Vanrell. (2006) Biocompatibility of elastin-like polymer poly(VPAVG) microparticles:in vitro andin vivo studies. Journal of Biomedical Materials Research Part A 78A:2, pages 343-351.
Crossref
Aniruddha Amrite & Uday Kompella. 2006. Nanoparticle Technology for Drug Delivery. Nanoparticle Technology for Drug Delivery.
Heather Sheardown & W. Mark Saltzman. 2006. Ocular Angiogenesis. Ocular Angiogenesis 393 408 .
Byeong-Cheol KANG, Kyung-Sun KANG & Yong-Soon LEE. (2005) Biocompatibility and Long-Term Toxicity of InnoPol Implant, a Biodegradable Polymer Scaffold. Experimental Animals 54:1, pages 37-52.
Crossref
Weibiao Huang, Brian Carlsen, Isabella Wulur, George Rudkin, Kenji Ishida, Benjamin Wu, Dean T. Yamaguchi & Timothy A. Miller. (2004) BMP-2 exerts differential effects on differentiation of rabbit bone marrow stromal cells grown in two-dimensional and three-dimensional systems and is required for in vitro bone formation in a PLGA scaffold. Experimental Cell Research 299:2, pages 325-334.
Crossref
Tsutomu Yasukawa, Yuichiro Ogura, Yasuhiko Tabata, Hideya Kimura, Peter Wiedemann & Yoshihito Honda. (2004) Drug delivery systems for vitreoretinal diseases. Progress in Retinal and Eye Research 23:3, pages 253-281.
Crossref
Marta Merodio, Juan Manuel Irache, Fatemeh Valamanesh & Massoud Mirshahi. (2002) Ocular disposition and tolerance of ganciclovir-loaded albumin nanoparticles after intravitreal injection in rats. Biomaterials 23:7, pages 1587-1594.
Crossref
Denis Labarre & Marie-Paule Carreno. 2002. Integrated Biomaterials Science. Integrated Biomaterials Science 691 734 .
O Felt, S Einmahl, P Furrer, V Baeyens & R Gurny. 2001. Polymeric Biomaterials, Revised and Expanded. Polymeric Biomaterials, Revised and Expanded.
Rocio Herrero-Vanrell & Miguel F Refojo. (2001) Biodegradable microspheres for vitreoretinal drug delivery. Advanced Drug Delivery Reviews 52:1, pages 5-16.
Crossref
Paul A. Burke & Scott D. Putney. 2001. Recombinant Protein Drugs. Recombinant Protein Drugs 151 168 .
Noriyuki Kunou, Yuichiro Ogura, Yoshihito Honda, Suong-Hyu Hyon & Yoshito Ikada. (2000) Biodegradable scleral implant for controlled intraocular delivery of betamethasone phosphate. Journal of Biomedical Materials Research 51:4, pages 635-641.
Crossref
Paul Burke & Scott Putney. 2000. Sustained-Release Injectable Products. Sustained-Release Injectable Products 371 407 .
Monique J. Bruining, Petra S. Edelbroek-Hoogendoorn, Harri�t G. T. Blaauwgeers, Cornelia M. Mooy, Fred H. Hendrikse & Leo H. Koole. (1999) New biodegradable networks of poly(N-vinylpyrrolidinone) designed for controlled nonburst degradation in the vitreous body. Journal of Biomedical Materials Research 47:2, pages 189-197.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.